NLTX / Neoleukin Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Neoleukin Therapeutics, Inc.
US ˙ NASDAQ ˙ US64049K1043
DENNA SYMBOL ÄR INTE LÄNGRE AKTIV

Insideraktier8 581 213 shares
Insider Sentiment Score

Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.

Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.

Uppdateringsfrekvens: Dagligen

Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.

Office Sentiment Score

Officersentiment Score hittar företag som köps av Corporate Officers.

Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.

Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.

Uppdateringsfrekvens: Dagligen

Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.

Viktiga insidernyckeltal

Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.

Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).

Nettoantalet insiders som köper (rankning)

N/A

Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).

Procent av flytande köpta av insiders (ranking)

N/A

Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.

Insiderhandelsdiagram

Neoleukin Therapeutics, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.

Insiderlista och lönsamhetsstatistik

Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.

See our leaderboard of most profitable insider traders.

Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad

Report errors via our new Insider Auditing Tool

Track Records av insiderköp - Kortsiktig vinstanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i NLTX / Neoleukin Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Max
Pris vid
Max
Maximal
vinst ($)
Maximal avkastning (%)
2024-11-26 Samsara BioCapital GP, LLC 2 000 27,5000 2 000 27,5000 55 000 0 26.8700 −1 260 −2,29
2024-11-26 Samsara BioCapital GP, LLC 15 219 26,7300 15 219 26,7300 406 804
2024-11-26 Samsara BioCapital GP, LLC 10 803 26,0100 10 803 26,0100 280 986
2024-11-26 Samsara BioCapital GP, LLC 20 748 24,9100 20 748 24,9100 516 833
2024-11-22 McMinn Rachel 47 500 20,4000 47 500 20,4000 969 000
2024-11-22 Cvijic Christine Mikail 24 000 20,4750 24 000 20,4750 491 400
2023-08-17 BAKER BROS. ADVISORS LP 7 676 0,6924 1 535 3,4620 5 315
2023-08-17 BAKER BROS. ADVISORS LP 93 091 0,6924 18 618 3,4620 64 456
2023-08-17 BAKER BROS. ADVISORS LP 5 041 0,6928 1 008 3,4640 3 492

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

NLTX / Neoleukin Therapeutics, Inc. Insider Trades
Track Records av insiderförsäljning - Kortsiktig förlustanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i NLTX / Neoleukin Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Min
Pris vid
Min
Maximal förlust
undvikits ($)
Maximal förlust
undvikits ($)
2025-03-13 Cvijic Christine Mikail 4 501 16,9400 4 501 16,9400 76 247 26 7.3400 −43 209 −56,67
2023-08-11 Smith Sean Michael 1 323 0,6184 265 3,0920 818
2023-04-03 Patel Priti 3 769 0,6919 754 3,4595 2 608
2023-02-02 Smith Sean Michael 3 316 0,5972 663 2,9860 1 980
2023-02-02 Patel Priti 14 380 0,5972 2 876 2,9860 8 588
2022-08-10 Smith Sean Michael 1 655 0,9914 331 4,9570 1 641
2022-05-02 Patel Priti 5 538 1,2186 1 108 6,0930 6 749
2021-03-17 Ho Robert 6 497 11,0137 1 299 55,0685 71 556
2020-04-02 Redmile Group, LLC 100 11,8200 20 59,1000 1 182

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

NLTX / Neoleukin Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.

Fil
datum
Handel
datum
Schema Insider Ticker Värdepappertitel Kod 10b5-1 Direkta Utövningspris Enhet
pris
Enheter
ändrad
Värde
ändrad (1K)
Kvarvarande
Optioner
Kvarvarande
Aktier
2025-05-15 2025-05-14 4 Cobb Stuart NGNE Common Stock S - Sale D 15,1542 −6 797 −103 20 794
2025-03-28 2025-03-26 4 Cobb Stuart NGNE Common Stock A - Award D 7 200 27 591
2025-03-28 2025-03-26 4 Cvijic Christine Mikail NGNE Common Stock A - Award D 20 300 92 643
2025-03-28 2025-03-26 4 Jordan Julie NGNE Common Stock A - Award D 8 400 8 400
2025-03-28 2025-03-26 4 McMinn Rachel NGNE Common Stock A - Award D 23 900 1 274 259
2025-03-17 2025-03-13 4 Cvijic Christine Mikail NGNE Common Stock S - Sale D 16,9400 −4 501 −76 72 343
2024-11-27 2024-11-26 4 Samsara BioCapital GP, LLC By Samsara BioCapital, L.P. NGNE Common Stock P - Purchase I 27,5000 2 000 55 1 717 127
2024-11-27 2024-11-26 4 Samsara BioCapital GP, LLC By Samsara BioCapital, L.P. NGNE Common Stock P - Purchase I 26,7300 15 219 407 1 715 127
2024-11-27 2024-11-26 4 Samsara BioCapital GP, LLC By Samsara BioCapital, L.P. NGNE Common Stock P - Purchase I 26,0100 10 803 281 1 699 908
2024-11-27 2024-11-26 4 Samsara BioCapital GP, LLC By Samsara BioCapital, L.P. NGNE Common Stock P - Purchase I 24,9100 20 748 517 1 689 105
2024-11-27 3 Samsara BioCapital GP, LLC By Samsara BioCapital, L.P. NGNE Common Stock I 1 668 357
2024-11-25 2024-11-22 4 McMinn Rachel NGNE Common Stock P - Purchase D 20,4000 47 500 969 1 297 859
2024-11-25 2024-11-22 4 Cvijic Christine Mikail NGNE Common Stock P - Purchase D 20,4750 24 000 491 76 844
2024-03-14 2024-03-13 4 Cvijic Christine Mikail NGNE Common Stock A - Award D 31 903 52 844
2024-03-14 2024-03-13 4 Cobb Stuart NGNE Common Stock A - Award D 20 391 20 391
2023-12-26 3 Cvijic Christine Mikail NGNE Common Stock D 20 941
2023-12-26 3 McMinn Rachel NGNE Common Stock D 1 250 359
2023-10-10 2023-10-05 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock X - Other I 535 601 1 658 190
2023-10-10 2023-10-05 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock X - Other I 57 049 155 874
2023-08-17 2023-08-17 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 0,6928 61 134 42 5 612 949
2023-08-17 2023-08-17 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 0,6928 5 041 3 494 133
2023-08-17 2023-08-17 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 0,6924 93 091 64 5 551 815
2023-08-17 2023-08-17 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 0,6924 7 676 5 489 092
2023-08-17 2023-08-16 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 0,6828 4 434 3 5 458 724
2023-08-17 2023-08-16 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 0,6828 366 0 481 416
2023-08-17 2023-08-16 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 0,6805 207 676 141 5 454 290
2023-08-17 2023-08-16 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 0,6805 17 124 12 481 050
2023-08-17 2023-08-15 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 0,6650 4 342 3 5 246 614
2023-08-17 2023-08-15 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 0,6650 358 0 463 926
2023-08-17 2023-08-15 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 0,6308 1 740 581 1 098 5 242 272
2023-08-17 2023-08-15 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 0,6308 143 519 91 463 568
2023-08-14 2023-08-11 4 Smith Sean Michael NLTX Common Stock S - Sale D 0,6184 −1 323 −1 21 637
2023-08-14 2023-08-10 4 Smith Sean Michael NLTX Common Stock M - Exercise D 5 000 22 960
2023-04-04 2023-04-03 4 Patel Priti NLTX Common Stock S - Sale D 0,6919 −3 769 −3 37 313
2023-04-04 2023-03-31 4 Patel Priti NLTX Common Stock M - Exercise D 10 000 41 082
2023-02-03 2023-02-02 4 Patel Priti NLTX Common Stock S - Sale D 0,5972 −14 380 −9 31 082
2023-02-03 2023-02-01 4 Patel Priti NLTX Common Stock M - Exercise D 35 000 45 462
2023-02-03 2023-02-02 4 Smith Sean Michael NLTX Common Stock S - Sale D 0,5972 −3 316 −2 15 960
2023-02-03 2023-02-01 4 Smith Sean Michael NLTX Common Stock M - Exercise D 12 500 19 276
2022-08-12 2022-08-10 4 Smith Sean Michael NLTX Common Stock S - Sale D 0,9914 −1 655 −2 6 776
2022-08-12 2022-08-10 4 Smith Sean Michael NLTX Common Stock M - Exercise D 5 000 8 431
2022-05-16 2022-05-12 4 SIMPSON TODD E NLTX Stock Option (Right to Buy) A - Award D 1,07 25 000 25 000
2022-05-16 2022-05-12 4 PALEKAR ROHAN NLTX Stock Option (Right to Buy) A - Award D 1,07 25 000 25 000
2022-05-16 2022-05-12 4 Lavelle Erin NLTX Stock Option (Right to Buy) A - Award D 1,07 25 000 25 000
2022-05-16 2022-05-12 4 Noonberg Sarah B. NLTX Stock Option (Right to Buy) A - Award D 1,07 25 000 25 000
2022-05-16 2022-05-12 4 Babler Martin NLTX Stock Option (Right to Buy) A - Award D 1,07 25 000 25 000
2022-05-16 2022-05-12 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Non-Qualified Stock Option (right to buy) A - Award I 1,07 25 000 25 000
2022-05-03 2022-05-02 4 Patel Priti NLTX Common Stock S - Sale D 1,2186 −5 538 −7 6 462
2022-05-03 2022-04-30 4 Patel Priti NLTX Restricted Stock Units M - Exercise D 0,00 10 000 10 000
2022-05-03 2022-04-30 4 Patel Priti NLTX Common Stock M - Exercise D 10 000 12 000
2022-03-15 2022-03-14 4 Cochener Donna NLTX Stock Option (Right to Buy) A - Award D 1,81 400 000 400 000
2022-03-04 2022-03-02 4 PALEKAR ROHAN NLTX Stock Option (Right to Buy) A - Award D 2,72 50 000 50 000
2022-03-03 3 Smith Sean Michael NLTX Common Stock D 3 431
2022-03-03 2022-03-02 4 Smith Sean Michael NLTX Stock Option (Right to Buy) A - Award D 2,72 80 000 80 000
2022-02-14 2021-10-26 5 DRACHMAN JONATHAN G NLTX Common Stock G - Gift I 75 000 100 000
2022-02-14 2021-10-26 5 DRACHMAN JONATHAN G NLTX Common Stock G - Gift I 75 000 100 000
2022-02-14 2021-10-26 5 DRACHMAN JONATHAN G NLTX Common Stock G - Gift D −75 000 2 198 686
2022-02-14 2021-10-26 5 DRACHMAN JONATHAN G NLTX Common Stock G - Gift D −75 000 2 198 686
2022-02-02 2022-02-01 4 Walkey Carl NLTX Restricted Stock Units A - Award D 0,00 55 000 55 000
2022-02-02 2022-02-01 4 Patel Priti NLTX Restricted Stock Units A - Award D 0,00 70 000 70 000
2022-02-02 2022-02-01 4 Ho Robert NLTX Restricted Stock Units A - Award D 0,00 70 000 70 000
2021-08-26 2021-08-25 4 DRACHMAN JONATHAN G NLTX Common Stock P - Purchase I 6,4490 25 000 161 25 000
2021-08-26 2021-08-25 4 DRACHMAN JONATHAN G NLTX Common Stock P - Purchase I 6,4490 25 000 161 25 000
2021-08-26 2021-08-24 4 DRACHMAN JONATHAN G NLTX Common Stock P - Purchase D 6,1110 100 000 611 2 348 686
2021-08-05 2021-08-03 4 Walkey Carl NLTX Stock Option (Right to Buy) A - Award D 6,80 100 000 100 000
2021-08-05 2021-08-03 4 Vance Holly NLTX Stock Option (Right to Buy) A - Award D 6,80 100 000 100 000
2021-08-05 2021-08-03 4 Patel Priti NLTX Stock Option (Right to Buy) A - Award D 6,80 50 000 50 000
2021-08-05 2021-08-03 4 Ho Robert NLTX Stock Option (Right to Buy) A - Award D 6,80 190 000 190 000
2021-08-05 2021-08-03 4 DRACHMAN JONATHAN G NLTX Stock Option (Right to Buy) A - Award D 6,80 400 000 400 000
2021-06-17 2021-06-16 4 Walkey Carl NLTX Common Stock S - Sale D 10,1900 −600 −6 1 352 489
2021-06-11 2021-06-09 4 Walkey Carl NLTX Common Stock S - Sale D 10,8246 −650 −7 1 353 089
2021-06-09 2021-06-08 4 Walkey Carl NLTX Common Stock S - Sale D 11,0000 −600 −7 1 353 739
2021-06-07 2021-06-04 4 Walkey Carl NLTX Common Stock S - Sale D 10,0000 −600 −6 1 354 339
2021-06-07 2021-06-04 4 DRACHMAN JONATHAN G NLTX Common Stock P - Purchase D 9,6082 10 000 96 2 248 686
2021-06-07 2021-06-03 4 DRACHMAN JONATHAN G NLTX Common Stock P - Purchase D 9,4818 40 000 379 2 238 686
2021-05-26 2021-05-26 4 Walkey Carl NLTX Common Stock S - Sale D 10,0000 −600 −6 1 354 939
2021-05-21 2021-05-19 4 Walkey Carl NLTX Common Stock S - Sale D 10,6300 −600 −6 1 355 539
2021-05-13 2021-05-11 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Non-Qualified Stock Option (right to buy) A - Award I 11,40 25 000 25 000
2021-05-13 2021-05-11 4 Babler Martin NLTX Stock Option (Right to Buy) A - Award D 11,40 25 000 25 000
2021-05-13 2021-05-11 4 Lavelle Erin M. NLTX Stock Option (Right to Buy) A - Award D 11,40 25 000 25 000
2021-05-13 2021-05-11 4 Noonberg Sarah B. NLTX Stock Option (Right to Buy) A - Award D 11,40 25 000 25 000
2021-05-13 2021-05-11 4 Williams Lewis T NLTX Stock Option (Right to Buy) A - Award D 11,40 25 000 25 000
2021-05-13 2021-05-11 4 SIMPSON TODD E NLTX Stock Option (Right to Buy) A - Award D 11,40 25 000 25 000
2021-05-12 2021-05-12 4 Walkey Carl NLTX Common Stock S - Sale D 11,0900 −1 200 −13 1 354 762
2021-05-06 2021-05-05 4 Walkey Carl NLTX Common Stock S - Sale D 11,3000 −1 200 −14 1 355 962
2021-05-04 2021-04-30 4 Patel Priti NLTX Stock Option (Right to Buy) A - Award D 12,49 475 000 475 000
2021-05-04 2021-04-30 4 Patel Priti NLTX Restricted Stock Units A - Award D 0,00 20 000 20 000
2021-04-30 2021-04-28 4 Walkey Carl NLTX Common Stock S - Sale D 12,5800 −2 400 −30 1 357 162
2021-04-27 2021-04-26 4 Walkey Carl NLTX Common Stock S - Sale D 13,0000 −600 −8 1 359 562
2021-04-22 2021-04-21 4 Walkey Carl NLTX Common Stock S - Sale D 11,9800 −1 800 −22 1 360 162
2021-04-16 2021-04-14 4 Walkey Carl NLTX Common Stock S - Sale D 12,2200 −1 800 −22 1 361 962
2021-04-08 2021-04-07 4 Walkey Carl NLTX Common Stock S - Sale D 12,0200 −1 800 −22 1 363 762
2021-04-06 2021-04-05 4 Walkey Carl NLTX Common Stock S - Sale D 13,0000 −600 −8 1 365 562
2021-04-02 2021-03-31 4 Walkey Carl NLTX Common Stock S - Sale D 11,9600 −1 800 −22 1 366 162
2021-03-24 2021-03-24 4 Walkey Carl NLTX Common Stock S - Sale D 11,9533 −1 800 −22 1 367 962
2021-03-24 2021-03-22 4 Walkey Carl NLTX Common Stock S - Sale D 12,0000 −600 −7 1 369 762
2021-03-18 2021-03-17 4 Walkey Carl NLTX Common Stock S - Sale D 11,3600 −1 200 −14 1 370 362
2021-03-18 2021-03-17 4 Ho Robert NLTX Common Stock S - Sale D 11,0137 −6 497 −72 21 503
2021-03-18 2021-03-16 4 Ho Robert NLTX Restricted Stock Units M - Exercise D 0,00 25 000 50 000
2021-03-18 2021-03-16 4 Ho Robert NLTX Common Stock M - Exercise D 25 000 28 000
2021-03-11 2021-03-10 4 Walkey Carl NLTX Common Stock S - Sale D 11,9667 −1 800 −22 1 371 562
2021-03-04 2021-03-03 4 Walkey Carl NLTX Common Stock S - Sale D 11,8667 −1 800 −21 1 373 362
2021-02-25 2021-02-25 4 Walkey Carl NLTX Common Stock S - Sale D 13,0000 −600 −8 1 375 162
2021-02-25 2021-02-24 4 Walkey Carl NLTX Common Stock S - Sale D 12,1400 −1 800 −22 1 375 762
2021-02-18 2021-02-17 4 Walkey Carl NLTX Common Stock S - Sale D 12,7000 −2 400 −30 1 377 562
2021-02-12 2021-02-10 4 Walkey Carl NLTX Common Stock S - Sale D 14,2000 −3 000 −43 1 379 962
2021-02-09 2021-02-05 4 Walkey Carl NLTX Common Stock S - Sale D 14,0000 −600 −8 1 382 962
2021-02-05 2021-02-03 4 Walkey Carl NLTX Common Stock S - Sale D 13,2300 −2 400 −32 1 383 562
2021-02-02 2021-01-30 4 Walkey Carl NLTX Stock Option (Right to Buy) A - Award D 12,60 45 000 45 000
2021-02-02 3 Walkey Carl NLTX Common Stock D 1 385 962
2020-12-23 2020-07-07 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Pre-Funded Warrants P - Purchase I 518 555 10 283 888
2020-12-23 2020-07-07 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Pre-Funded Warrants P - Purchase I 38 974 1 199 122
2020-12-23 2020-07-07 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 15,2500 394 360 6 014 3 501 691
2020-12-23 2020-07-07 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 15,2500 29 640 452 320 049
2020-10-20 2020-10-19 4 Vance Holly NLTX Stock Option (Right to Buy) A - Award D 12,30 220 000 220 000
2020-09-10 2020-09-08 4 Babler Martin NLTX Stock Option (Right to Buy) A - Award D 12,25 50 000 50 000
2020-08-12 2020-08-10 4 DRACHMAN JONATHAN G NLTX Stock Option (Right to Buy) A - Award D 12,00 420 000 420 000
2020-08-12 2020-08-10 4 Ho Robert NLTX Stock Option (Right to Buy) A - Award D 12,00 90 000 90 000
2020-06-02 2020-06-01 4 Lavelle Erin M. NLTX Stock Option (Right to Buy) A - Award D 13,58 50 000 50 000
2020-05-07 2020-05-05 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Non-Qualified Stock Option (right to buy) A - Award I 12,84 25 000 25 000
2020-05-07 2020-05-05 4 Nolan Sean P. NLTX Stock Option (Right to Buy) A - Award D 12,84 25 000 25 000
2020-05-07 2020-05-05 4 Noonberg Sarah B. NLTX Stock Option (Right to Buy) A - Award D 12,84 25 000 25 000
2020-05-07 2020-05-05 4 SIMPSON TODD E NLTX Stock Option (Right to Buy) A - Award D 12,84 25 000 25 000
2020-05-07 2020-05-05 4 Williams Lewis T NLTX Stock Option (Right to Buy) A - Award D 12,84 25 000 25 000
2020-04-06 2020-04-02 4 Redmile Group, LLC NLTX Common Stock S - Sale I 11,8200 −100 −1 4 041 211
2020-04-06 2020-04-02 4 Redmile Group, LLC NLTX Common Stock S - Sale I 11,3039 −9 734 −110 4 041 311
2020-04-06 2020-04-02 4 Redmile Group, LLC NLTX Common Stock P - Purchase I 11,8506 1 000 12 4 051 045
2020-04-06 2020-04-02 4 Redmile Group, LLC NLTX Common Stock P - Purchase I 11,3605 38 300 435 4 050 045
2020-04-06 2020-04-01 4 Redmile Group, LLC NLTX Common Stock S - Sale I 11,8650 −200 −2 4 011 745
2020-04-06 2020-04-01 4 Redmile Group, LLC NLTX Common Stock S - Sale I 11,0616 −9 634 −107 4 011 945
2020-04-06 2020-04-01 4 Redmile Group, LLC NLTX Common Stock P - Purchase I 11,6517 9 000 105 4 021 579
2020-04-06 2020-04-01 4 Redmile Group, LLC NLTX Common Stock P - Purchase I 10,9482 33 500 367 4 012 579
2020-04-06 2020-03-31 4 Redmile Group, LLC NLTX Common Stock P - Purchase I 10,7079 7 500 80 3 979 079
2020-04-06 2020-03-31 4 Redmile Group, LLC NLTX Common Stock P - Purchase I 10,1813 22 500 229 3 971 579
2020-04-06 2020-03-30 4 Redmile Group, LLC NLTX Common Stock P - Purchase I 10,2744 2 700 28 3 949 079
2020-04-06 2020-03-30 4 Redmile Group, LLC NLTX Common Stock P - Purchase I 9,9050 29 800 295 3 946 379
2020-04-06 2020-03-27 4 Redmile Group, LLC NLTX Common Stock P - Purchase I 9,2079 50 000 460 3 916 579
2020-04-06 3 Green Jeremy NLTX Common Stock I 7 733 158
2020-04-06 3 Green Jeremy NLTX Common Stock I 7 733 158
2020-04-06 3 Green Jeremy NLTX Common Stock I 7 733 158
2020-04-06 3 Green Jeremy NLTX Common Stock I 7 733 158
2020-03-16 3 Ho Robert NLTX Common Stock D 6 000
2020-03-16 3 Ho Robert NLTX Common Stock D 6 000
2020-03-16 3 Ho Robert NLTX Common Stock D 6 000
2020-03-16 2020-03-16 4 Ho Robert NLTX Stock Option (Right to Buy) A - Award D 6,44 200 000 200 000
2020-03-16 2020-03-16 4 Ho Robert NLTX Restricted Stock Units A - Award D 0,00 75 000 75 000
2019-12-20 2019-12-20 4 DRACHMAN JONATHAN G NLTX Common Stock P - Purchase D 8,4000 119 047 1 000 2 198 686
2019-12-20 2019-11-12 4 DRACHMAN JONATHAN G NLTX Common Stock C - Conversion D 1 261 600 2 079 639
2019-12-20 2019-11-12 4 DRACHMAN JONATHAN G NLTX Series A Preferred Stock C - Conversion D −12 616 0
2019-12-20 2019-12-20 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Pre-funded Warrants A - Award I 9 765 333 9 765 333
2019-12-20 2019-12-20 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Pre-funded Warrants A - Award I 1 160 148 1 161 048
2019-12-20 2019-12-20 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock D - Sale to Issuer I −9 765 333 3 107 331
2019-12-20 2019-12-20 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock D - Sale to Issuer I −1 160 148 290 409
2019-12-20 2019-12-20 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 8,4000 2 767 505 23 247 12 872 664
2019-12-20 2019-12-20 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Common Stock P - Purchase I 8,4000 250 037 2 100 1 450 557
2019-10-15 2019-10-10 4 BAKER BROS. ADVISORS LP See Footnotes NLTX Non-Qualified Stock Option (right to buy) A - Award I 2,82 22 000 22 000
2019-10-15 2019-10-10 4 Williams Lewis T NLTX Stock Option (right to buy) A - Award D 2,82 22 000 22 000
2019-10-15 2019-10-10 4 Nolan Sean P. NLTX Stock Option (right to buy) A - Award D 2,82 22 000 22 000
2019-10-15 2019-10-10 4 Noonberg Sarah B. NLTX Stock Option (right to buy) A - Award D 2,82 22 000 22 000
2019-10-15 2019-10-10 4 SIMPSON TODD E NLTX Stock Option (right to buy) A - Award D 2,82 22 000 22 000
2019-09-13 2019-08-08 4/A DRACHMAN JONATHAN G NLTX Series A Preferred Stock A - Award D 12 616 12 616
2019-09-13 2019-08-08 4/A DRACHMAN JONATHAN G NLTX Common Stock A - Award D 568 039 568 039
2019-09-11 2019-09-11 4 DRACHMAN JONATHAN G NLTX Common Stock P - Purchase D 3,2975 136 436 450 584 428
2019-09-11 2019-09-10 4 DRACHMAN JONATHAN G NLTX Common Stock P - Purchase D 3,0834 36 742 113 447 992
2019-09-11 2019-09-09 4 DRACHMAN JONATHAN G NLTX Common Stock P - Purchase D 2,8450 76 822 219 411 250
2019-09-04 2019-08-31 4 DRACHMAN JONATHAN G NLTX Stock Option (Right to Buy) A - Award D 2,80 1 650 000 1 650 000
2019-08-12 2019-08-08 4 DRACHMAN JONATHAN G NLTX Series A Preferred Stock A - Award D 7 428 7 428
2019-08-12 2019-08-08 4 DRACHMAN JONATHAN G NLTX Common Stock A - Award D 334 428 334 428
2019-08-08 2019-08-07 4 BAKER BROS. ADVISORS LP See footnotes AQXP Common Stock P - Purchase I 3,1529 50 436 159 10 105 159
2019-08-08 2019-08-07 4 BAKER BROS. ADVISORS LP See footnotes AQXP Common Stock P - Purchase I 3,1529 4 564 14 1 200 520
2019-08-08 2019-08-07 4 BAKER BROS. ADVISORS LP See footnotes AQXP Common Stock P - Purchase I 3,0244 209 382 633 10 054 723
2019-08-08 2019-08-07 4 BAKER BROS. ADVISORS LP See footnotes AQXP Common Stock P - Purchase I 3,0244 18 943 57 1 195 956
2019-08-08 2019-08-07 4 BAKER BROS. ADVISORS LP See footnotes AQXP Common Stock P - Purchase I 2,9576 5 869 17 9 845 341
2019-08-08 2019-08-07 4 BAKER BROS. ADVISORS LP See footnotes AQXP Common Stock P - Purchase I 2,9576 531 2 1 177 013
2019-08-08 2019-08-06 4 BAKER BROS. ADVISORS LP See footnotes AQXP Common Stock P - Purchase I 2,8469 65 568 187 9 839 472
2019-08-08 2019-08-06 4 BAKER BROS. ADVISORS LP See footnotes AQXP Common Stock P - Purchase I 2,8469 5 932 17 1 176 482
2019-08-08 2019-08-06 4 BAKER BROS. ADVISORS LP See footnotes AQXP Common Stock P - Purchase I 2,8328 9 445 27 9 773 904
2019-08-08 2019-08-06 4 BAKER BROS. ADVISORS LP See footnotes AQXP Common Stock P - Purchase I 2,8328 855 2 1 170 550
2018-08-09 2018-08-07 4 Alam Kamran AQXP Stock Option (Right to Buy) A - Award D 3,07 195 000 195 000
2018-08-09 2018-08-07 4 MacKenzie Lloyd AQXP Stock Option (Right to Buy) A - Award D 3,07 145 000 145 000
2018-08-09 2018-08-07 4 McCloskey Shelley AQXP Stock Option (Right to Buy) A - Award D 3,07 75 000 75 000
2018-08-09 2018-08-07 4 Main David AQXP Stock Option (Right to Buy) A - Award D 3,07 415 000 415 000
2018-05-16 2018-05-14 4 LEVITT DANIEL J AQXP Stock Option (Right to Buy) M - Exercise D 10,56 −3 906 0
2018-05-16 2018-05-14 4 LEVITT DANIEL J AQXP Common Stock S - Sale D 12,6700 −3 906 −49 0
2018-05-16 2018-05-14 4 LEVITT DANIEL J AQXP Common Stock M - Exercise D 10,5600 3 906 41 3 906
2018-05-09 2018-05-07 4 Pelzer Robert AQXP Stock Option (Right to Buy) A - Award D 13,10 15 000 15 000
2018-05-09 2018-05-07 4 SIMPSON TODD E AQXP Stock Option (Right to Buy) A - Award D 13,10 15 000 15 000
2018-05-09 2018-05-07 4 LEVITT DANIEL J AQXP Stock Option (Right to Buy) A - Award D 13,10 15 000 15 000
2018-05-09 2018-05-07 4 Nolan Sean P. AQXP Stock Option (Right to Buy) A - Award D 13,10 15 000 15 000
2018-05-09 2018-05-07 4 Bridger Gary AQXP Stock Option (Right to Buy) A - Award D 13,10 15 000 15 000
2018-05-09 2018-05-07 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Non-Qualified Stock Option (right to buy) A - Award I 13,10 30 000 30 000
2018-03-19 2018-03-15 4 MacKenzie Lloyd AQXP Stock Option (Right to Buy) M - Exercise D 10,56 −1 302 0
2018-03-19 2018-03-15 4 MacKenzie Lloyd AQXP Common Stock S - Sale D 14,6304 −1 302 −19 0
2018-03-19 2018-03-15 4 MacKenzie Lloyd AQXP Common Stock M - Exercise D 10,5600 1 302 14 1 302
2018-03-13 2018-03-09 4 Troupin Barbara AQXP Stock Option (Right to Buy) A - Award D 16,55 75 000 75 000
2018-03-13 2018-03-09 4 Alam Kamran AQXP Stock Option (Right to Buy) A - Award D 16,55 75 000 75 000
2018-03-13 2018-03-09 4 Jenkins Abigail AQXP Stock Option (Right to Buy) A - Award D 16,55 75 000 75 000
2018-03-13 2018-03-09 4 MacKenzie Lloyd AQXP Stock Option (Right to Buy) A - Award D 16,55 75 000 75 000
2018-03-13 2018-03-09 4 Main David AQXP Stock Option (Right to Buy) A - Award D 16,55 225 000 225 000
2018-03-13 2018-03-09 4 McCloskey Shelley AQXP Stock Option (Right to Buy) A - Award D 16,55 45 000 45 000
2017-06-05 2017-06-05 4 Main David AQXP Stock Option (Right to Buy) M - Exercise D 9,60 −3 625 0
2017-06-05 2017-06-05 4 Main David AQXP Common Stock S - Sale D 13,1575 −3 625 −48 71 530
2017-06-05 2017-06-05 4 Main David AQXP Common Stock M - Exercise D 9,6000 3 625 35 75 155
2017-06-05 2017-06-02 4 Main David AQXP Stock Option (Right to Buy( M - Exercise D 9,60 −6 000 3 625
2017-06-05 2017-06-02 4 Main David AQXP Common Stock S - Sale D 13,5933 −6 000 −82 71 530
2017-06-05 2017-06-02 4 Main David AQXP Common Stock M - Exercise D 9,6000 6 000 58 77 530
2017-06-05 2017-06-01 4 Main David AQXP Stock Option (Right to Buy) M - Exercise D 9,60 −6 000 9 625
2017-06-05 2017-06-01 4 Main David AQXP Common Stock S - Sale D 12,9980 −6 000 −78 71 530
2017-06-05 2017-06-01 4 Main David AQXP Common Stock M - Exercise D 9,6000 6 000 58 77 530
2017-05-10 2017-05-08 4 SIMPSON TODD E AQXP Stock Option (Right to Buy) A - Award D 13,74 9 000 9 000
2017-05-10 2017-05-08 4 Nolan Sean P. AQXP Stock Option (Right to Buy) A - Award D 13,74 9 000 9 000
2017-05-10 2017-05-08 4 Pelzer Robert AQXP Stock Option (Right to Buy) A - Award D 13,74 9 000 9 000
2017-05-10 2017-05-08 4 LEVITT DANIEL J AQXP Stock Option (Right to Buy) A - Award D 13,74 9 000 9 000
2017-05-10 2017-05-08 4 Bridger Gary AQXP Stock Option (Right to Buy) A - Award D 13,74 9 000 9 000
2017-05-09 2017-05-08 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Non-Qualified Stock Option (right to buy) A - Award I 13,74 36 000 36 000
2017-03-27 3 Neu Kelvin AQXP Common Stock D 72
2017-03-27 3 Neu Kelvin AQXP Common Stock D 72
2017-03-10 2017-03-08 4 McCloskey Shelley AQXP Stock Option (Right to Buy) A - Award D 17,35 30 000 30 000
2017-03-10 2017-03-08 4 Mitchell David Chilton AQXP Stock Option (Right to Buy) A - Award D 17,35 25 000 25 000
2017-03-10 2017-03-08 4 Troupin Barbara AQXP Stock Option (Right to Buy) A - Award D 17,35 40 000 40 000
2017-03-10 2017-03-08 4 MacKenzie Lloyd AQXP Stock Option (Right to Buy) A - Award D 17,35 50 000 50 000
2017-03-10 2017-03-08 4 Main David AQXP Stock Option (Right to Buy) A - Award D 17,35 185 000 185 000
2017-03-10 2017-03-08 4 Alam Kamran AQXP Stock Option (Right to Buy) A - Award D 17,35 80 000 80 000
2017-03-10 2017-03-08 4 Jenkins Abigail AQXP Stock Option (Right to Buy) A - Award D 17,35 80 000 80 000
2017-02-14 2016-01-10 5 McCloskey Shelley AQXP Stock Option (Right to Buy) A - Award D 10,09 35 000 35 000
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 17,7600 32 051 569 9 764 459
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 17,7600 3 389 60 1 169 695
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 17,5996 235 169 4 139 9 732 408
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 17,5996 24 871 438 1 166 306
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 16,3053 35 360 577 9 497 239
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 16,3053 3 739 61 1 141 435
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 15,6226 5 006 78 9 461 879
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 15,6226 529 8 1 137 696
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 15,1300 15 148 229 9 456 873
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 15,1300 1 602 24 1 137 167
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 16,1970 9 143 148 9 441 725
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 16,1970 967 16 1 135 565
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 15,3475 8 671 133 9 432 582
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 15,3475 917 14 1 134 598
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 16,8533 2 442 41 9 423 911
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 16,8533 258 4 1 133 681
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 15,3210 11 305 173 9 421 469
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 15,3210 1 195 18 1 133 423
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 16,7395 5 697 95 9 410 164
2017-01-09 2017-01-09 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 16,7395 603 10 1 132 228
2016-11-10 2016-11-08 4 Troupin Barbara AQXP Stock Option (Right to Buy) A - Award D 11,77 50 000 50 000
2016-10-06 3 Troupin Barbara AQXP No securities are benefically owned D 0
2016-09-21 2016-09-20 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 13,1497 12 550 165 1 131 625
2016-09-21 2016-09-20 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 12,2500 2 476 348 30 335 9 404 467
2016-09-21 2016-09-20 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 12,2500 294 707 3 610 1 119 075
2016-08-05 2016-08-03 4 Jenkins Abigail AQXP Stock Option (Right to Buy) A - Award D 8,97 50 000 50 000
2016-06-15 3 Jenkins Abigail AQXP No securities are beneficially owned D 0
2016-05-11 2016-05-09 4 LEVITT DANIEL J AQXP Stock Option (Right to Buy) A - Award D 7,73 7 500 7 500
2016-05-11 2016-05-09 4 SIMPSON TODD E AQXP Stock Option (Right to Buy) A - Award D 7,73 7 500 7 500
2016-05-11 2016-05-09 4 Pelzer Robert AQXP Stock Option (Right to Buy) A - Award D 7,73 7 500 7 500
2016-05-11 2016-05-09 4 Nolan Sean P. AQXP Stock Option (Right to Buy) A - Award D 7,73 7 500 7 500
2016-05-11 2016-05-09 4 Bridger Gary AQXP Stock Option (Right to Buy) A - Award D 7,73 7 500 7 500
2016-03-16 2016-03-16 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,1560 128 975 1 052 6 928 119
2016-03-16 2016-03-16 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,1560 14 046 115 824 368
2016-03-16 2016-03-16 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 7,9084 185 413 1 466 6 799 144
2016-03-16 2016-03-16 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 7,9084 20 192 160 810 322
2016-03-16 2016-03-16 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 7,6993 11 840 91 6 613 731
2016-03-16 2016-03-16 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 7,6993 1 289 10 790 130
2016-03-16 2016-03-15 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,0257 68 132 547 6 601 891
2016-03-16 2016-03-15 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,0257 7 420 60 788 841
2016-03-16 2016-03-15 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 7,8786 30 986 244 6 533 759
2016-03-16 2016-03-15 4 BAKER BROS. ADVISORS LP AQXP Common Stock P - Purchase I 7,8786 3 374 27 781 421
2016-03-14 2016-03-10 4 SHREWSBURY STEPHEN B AQXP Stock Option (Right to Buy) A - Award D 8,08 35 000 35 000
2016-03-14 2016-03-10 4 Main David AQXP Stock Option (Right to Buy) A - Award D 8,08 120 000 120 000
2016-03-14 2016-03-10 4 Alam Kamran AQXP Stock Option (Right to Buy) A - Award D 8,08 40 000 40 000
2016-03-14 2016-03-10 4 MacKenzie Lloyd AQXP Stock Option (Right to Buy) A - Award D 8,08 35 000 35 000
2016-03-14 2016-03-10 4 Mitchell David Chilton AQXP Stock Option (Right to Buy) A - Award D 8,08 25 000 25 000
2016-01-26 2016-01-26 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 10,9960 3 581 39 6 502 773
2016-01-26 2016-01-26 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 10,9960 395 4 778 047
2016-01-26 2016-01-26 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 10,8033 66 345 717 6 499 192
2016-01-26 2016-01-26 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 10,8033 7 318 79 777 652
2016-01-26 2016-01-25 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 11,2043 2 522 28 6 432 847
2016-01-26 2016-01-25 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 11,2043 278 3 770 334
2016-01-26 2016-01-25 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 10,9755 4 503 49 6 430 325
2016-01-26 2016-01-25 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 10,9755 497 5 770 056
2016-01-26 2016-01-25 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 11,2326 2 833 32 6 425 822
2016-01-26 2016-01-25 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 11,2326 312 4 769 559
2016-01-26 2016-01-22 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 10,6908 25 650 274 6 422 989
2016-01-26 2016-01-22 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 10,6908 2 810 30 769 247
2016-01-26 2016-01-22 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 10,6000 156 2 6 397 339
2016-01-26 2016-01-22 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 10,6000 17 0 766 437
2016-01-26 2016-01-22 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 10,6937 4 021 43 6 397 183
2016-01-26 2016-01-22 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 10,6937 440 5 766 420
2016-01-26 2016-01-22 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 10,7814 17 221 186 6 393 162
2016-01-26 2016-01-22 4 BAKER BROS. ADVISORS LP AQXP Common Stock P - Purchase I 10,7814 1 887 20 765 980
2016-01-20 2016-01-20 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,9000 1 734 15 6 375 941
2016-01-20 2016-01-20 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,9000 190 2 764 093
2016-01-20 2016-01-20 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,9572 27 996 251 6 374 207
2016-01-20 2016-01-20 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,9572 3 067 27 763 903
2016-01-20 2016-01-20 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,9559 13 789 123 6 346 211
2016-01-20 2016-01-20 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,9559 1 511 14 760 836
2016-01-20 2016-01-20 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 9,8852 57 453 568 6 332 422
2016-01-20 2016-01-20 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 9,8852 6 294 62 759 325
2016-01-20 2016-01-19 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 9,1537 14 313 131 6 274 969
2016-01-20 2016-01-19 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 9,1537 1 568 14 753 031
2016-01-20 2016-01-19 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 9,2149 10 123 93 6 260 656
2016-01-20 2016-01-19 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 9,2149 1 109 10 751 463
2016-01-20 2016-01-19 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 9,0757 45 903 417 6 250 533
2016-01-20 2016-01-19 4 BAKER BROS. ADVISORS LP AQXP Common Stock P - Purchase I 9,0757 5 029 46 750 354
2016-01-15 2016-01-15 4/A BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,5591 47 193 404 6 204 630
2016-01-15 2016-01-15 4/A BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,5591 5 196 44 745 325
2016-01-15 2016-01-15 4/A BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,9529 4 949 44 6 157 437
2016-01-15 2016-01-15 4/A BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,9529 545 5 740 129
2016-01-15 2016-01-15 4/A BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,8249 3 279 29 6 152 488
2016-01-15 2016-01-15 4/A BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,8249 361 3 739 584
2016-01-15 2016-01-15 4/A BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,0999 20 851 169 6 149 209
2016-01-15 2016-01-15 4/A BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,0999 2 296 19 739 223
2016-01-15 2016-01-14 4/A BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,0764 2 998 24 6 128 358
2016-01-15 2016-01-14 4/A BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,0764 330 3 736 927
2016-01-15 2016-01-14 4/A BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 7,9110 12 706 101 6 125 360
2016-01-15 2016-01-14 4/A BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 7,9110 1 399 11 736 597
2016-01-15 2016-01-14 4/A BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,1717 90 550 740 6 112 654
2016-01-15 2016-01-14 4/A BAKER BROS. ADVISORS LP AQXP Common Stock P - Purchase I 8,1717 9 970 81 735 198
2016-01-15 2016-01-15 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,5591 47 193 404 6 204 630
2016-01-15 2016-01-15 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,5591 5 196 44 745 325
2016-01-15 2016-01-15 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,9529 4 949 44 6 157 437
2016-01-15 2016-01-15 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,9529 545 5 740 129
2016-01-15 2016-01-15 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,8249 3 279 29 6 152 488
2016-01-15 2016-01-15 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,8249 361 3 739 584
2016-01-15 2016-01-15 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,0999 20 851 169 6 149 209
2016-01-15 2016-01-15 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,0999 2 296 19 739 223
2016-01-15 2016-01-14 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,0764 2 998 24 6 128 358
2016-01-15 2016-01-14 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,0764 330 3 736 927
2016-01-15 2016-01-14 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 7,9110 12 706 101 6 125 360
2016-01-15 2016-01-14 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 7,9110 1 399 11 736 597
2016-01-15 2016-01-14 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 8,1717 90 550 740 6 112 654
2016-01-15 2016-01-14 4 BAKER BROS. ADVISORS LP AQXP Common Stock P - Purchase I 8,1717 9 970 81 735 198
2015-12-23 3 McCloskey Shelley AQXP No securities are beneficially owned D 0
2015-11-03 2015-10-31 4 Bridger Gary AQXP Common Stock J - Other I −1 543 989 0
2015-09-11 2015-09-10 4 BAKER BROS. ADVISORS LP See Footnotes AQXP Common Stock P - Purchase I 15,5000 2 213 469 34 309 6 022 104
2015-09-11 2015-09-10 4 BAKER BROS. ADVISORS LP AQXP Common Stock P - Purchase I 15,5000 266 563 4 132 725 228
2015-08-26 2015-08-24 4 Mitchell David Chilton By spouse AQXP Common Stock P - Purchase I 17,8100 3 575 64 3 575
2015-08-14 2015-08-12 4 MacKenzie Lloyd AQXP Stock Option (Right to Buy) M - Exercise D 5,76 28 075 1 872
2015-08-14 2015-08-12 4 MacKenzie Lloyd AQXP Stock Option (Right to Buy) M - Exercise D 5,76 7 812 0
2015-08-14 2015-08-12 4 MacKenzie Lloyd AQXP Common Stock S - Sale D 18,6700 −35 887 −670 0
2015-08-14 2015-08-12 4 MacKenzie Lloyd AQXP Common Stock M - Exercise D 5,7600 28 075 162 35 887
2015-08-14 2015-08-12 4 MacKenzie Lloyd AQXP Common Stock M - Exercise D 5,7600 7 812 45 7 812
2015-08-14 2015-08-12 4 Alam Kamran AQXP Stock Option (Right to Buy) M - Exercise D 5,76 −20 833 0
2015-08-14 2015-08-12 4 Alam Kamran AQXP Stock Option (Right to Buy) M - Exercise D 5,76 −8 246 2 170
2015-08-14 2015-08-12 4 Alam Kamran AQXP Common Stock S - Sale D 18,6700 −29 079 −543 0
2015-08-14 2015-08-12 4 Alam Kamran AQXP Common Stock M - Exercise D 5,7600 20 833 120 29 079
2015-08-14 2015-08-12 4 Alam Kamran AQXP Common Stock M - Exercise D 5,7600 8 246 47 8 246
2015-08-13 2015-08-11 4 Mitchell David Chilton AQXP Common Stock P - Purchase D 24,3600 1 600 39 1 600
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 23,4112 −58 632 −1 373 975 403
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 22,5994 −44 268 −1 000 1 034 035
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 24,3129 −31 400 −763 1 078 303
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 20,3476 −25 931 −528 1 109 703
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 26,3213 −13 109 −345 1 135 634
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 25,3233 −12 726 −322 1 148 743
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 38,4947 −11 627 −448 1 161 469
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 36,3687 −10 544 −383 1 173 096
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 37,2264 −9 901 −369 1 183 640
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 39,5172 −9 142 −361 1 193 541
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 21,4506 −8 969 −192 1 202 683
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 27,3561 −8 565 −234 1 211 652
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 40,2955 −6 073 −245 1 220 217
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 35,6072 −3 207 −114 1 226 290
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 28,4670 −2 975 −85 1 229 497
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 41,2475 −2 840 −117 1 232 472
2015-08-12 2015-08-10 4 PFIZER INC AQXP Common Stock S - Sale D 29,0000 −18 −1 1 235 312
2015-08-12 2015-08-11 4 JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC, Inc. AQXP Common Stock S - Sale I 20,7400 −1 283 366 −26 617 100 000
2015-08-12 2015-08-10 4 JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC, Inc. AQXP Common Stock S - Sale I 31,6600 −231 455 −7 328 1 383 366
2015-08-10 3/A BAKER FELIX AQXP Common Stock D 2 260
2015-08-10 3/A BAKER FELIX AQXP Common Stock D 2 260
2015-08-10 3 667, L.P. AQXP Common Stock I 4 725 965
2015-08-10 3 667, L.P. AQXP Common Stock I 4 725 965
2015-08-10 3 667, L.P. AQXP Common Stock I 8 075 935
2015-08-10 3 667, L.P. AQXP Common Stock I 4 725 965
2015-08-10 3 667, L.P. AQXP Common Stock I 4 725 965
2015-08-10 3 667, L.P. AQXP Common Stock I 8 075 935
2015-08-10 3 667, L.P. AQXP Common Stock I 8 075 935
2015-08-10 3 667, L.P. AQXP Common Stock I 4 725 965
2015-08-10 3 667, L.P. AQXP Common Stock I 4 725 965
2015-08-10 3 667, L.P. AQXP Common Stock I 8 075 935
2015-08-10 3 667, L.P. AQXP Common Stock I 8 075 935
2015-08-10 3 667, L.P. AQXP Common Stock I 8 075 935
2015-08-10 3 667, L.P. AQXP Common Stock I 4 725 965
2015-08-10 3 667, L.P. AQXP Common Stock I 8 075 935
2015-03-16 2015-03-12 4 SHREWSBURY STEPHEN B AQXP Stock Option (Right to Buy) A - Award D 12,03 25 000 25 000
2015-03-16 2015-03-12 4 Nolan Sean P. AQXP Stock Option (Right to Buy) A - Award D 12,03 10 000 10 000
2015-03-16 2015-03-12 4 Main David AQXP Stock Option (Right to Buy) A - Award D 12,03 65 000 65 000
2015-03-16 2015-03-12 4 Pelzer Robert AQXP Stock Option (Right to Buy) A - Award D 12,03 5 000 5 000
2015-03-16 2015-03-12 4 SIMPSON TODD E AQXP Stock Option (Right to Buy) A - Award D 12,03 5 000 5 000
2015-03-16 2015-03-12 4 MacKenzie Lloyd AQXP Stock Option (Right to Buy) A - Award D 12,03 25 000 25 000
2015-03-16 2015-03-12 4 LEVITT DANIEL J AQXP Stock Option (Right to Buy) A - Award D 12,03 5 000 5 000
2015-03-16 2015-03-12 4 Bridger Gary AQXP Stock Option (Right to Buy) A - Award D 12,03 5 000 5 000
2015-03-16 2015-03-12 4 Alam Kamran AQXP Stock Option (Right to Buy) A - Award D 12,03 25 000 25 000
2015-02-09 2014-09-02 5 SHREWSBURY STEPHEN B AQXP Common Stock P - Purchase D 8,2200 400 3 400
2015-02-03 2014-03-12 4/A JOHNSON & JOHNSON By Johnson & Johnson Development Corporation AQXP Series C Preferred Stock C - Conversion I −379 543 0
2015-02-03 2014-03-12 4/A JOHNSON & JOHNSON By Johnson & Johnson Development Corporation AQXP Series B-2 Preferred Stock C - Conversion I −292 532 0
2015-02-03 2014-03-12 4/A JOHNSON & JOHNSON By Johnson & Johnson Development Corporation AQXP Series B-1 Preferred Stock C - Conversion I −293 884 0
2015-02-03 2014-03-12 4/A JOHNSON & JOHNSON By Johnson & Johnson Development Corporation AQXP Series A-2 Preferred Stock C - Conversion I −170 454 0
2015-02-03 2014-03-12 4/A JOHNSON & JOHNSON By Johnson & Johnson Development Corporation AQXP Series A-1 Preferred Stock C - Conversion I −255 681 0
2015-02-03 2014-03-12 4/A JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock P - Purchase I 11,0000 272 727 3 000 1 664 821
2015-02-03 2014-03-12 4/A JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock C - Conversion I 1 392 094 1 392 094
2015-01-13 2015-01-11 4 Mitchell David Chilton AQXP Stock Option (Right to Buy) A - Award D 9,51 35 000 35 000
2014-12-18 2014-12-17 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 7,5800 −1 593 −12 1 342 094
2014-12-18 2014-12-16 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 7,6300 −6 507 −50 1 343 687
2014-12-15 2014-12-12 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 7,5100 −3 645 −27 1 350 194
2014-12-15 2014-12-11 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 7,5000 −1 355 −10 1 353 839
2014-12-10 2014-12-10 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 7,7000 −1 300 −10 1 355 194
2014-12-10 2014-12-09 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 7,7300 −5 000 −39 1 356 494
2014-12-10 2014-12-08 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 7,6900 −2 000 −15 1 361 494
2014-12-05 2014-12-05 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 7,7800 −4 200 −33 1 363 494
2014-12-05 2014-12-04 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 7,7600 −10 073 −78 1 367 694
2014-12-05 2014-12-03 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 7,7500 −1 627 −13 1 377 767
2014-12-03 2014-12-01 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 7,5400 −1 200 −9 1 379 394
2014-11-26 2014-11-26 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 7,6000 −500 −4 1 380 594
2014-11-26 2014-11-25 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 7,8000 −1 500 −12 1 381 094
2014-11-24 2014-11-24 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 8,0200 −4 000 −32 1 382 594
2014-11-24 2014-11-21 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 8,2500 −2 400 −20 1 386 594
2014-11-24 2014-11-20 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock S - Sale I 8,2100 −3 100 −25 1 388 994
2014-05-12 2014-05-08 4 SHREWSBURY STEPHEN B AQXP Stock Option (Right to Buy) A - Award D 10,10 31 250 31 250
2014-05-12 2014-05-08 4 Main David AQXP Stock Option (Right to Buy) A - Award D 10,10 65 000 65 000
2014-05-12 2014-05-08 4 Alam Kamran AQXP Stock Option (Right to Buy) A - Award D 10,10 31 250 31 250
2014-05-12 2014-05-08 4 MacKenzie Lloyd AQXP Stock Option (Right to Buy) A - Award D 10,10 25 000 25 000
2014-03-14 2014-03-12 4 Main David AQXP Common Exchangeable Shares C - Conversion D −71 530 0
2014-03-14 2014-03-12 4 Main David AQXP Common Exchangeable Shares D - Sale to Issuer D 11,0000 −9 459 −104 0
2014-03-14 2014-03-12 4 Main David AQXP Common Stock C - Conversion D 71 530 71 530
2014-03-14 2014-03-12 4 Main David AQXP Common Special Voting Stock C - Conversion D −71 530 0
2014-03-14 2014-03-12 4 Main David AQXP Common Special Voting Stock D - Sale to Issuer D 11,0000 −9 459 −104 71 530
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series C Exchangeable Shares C - Conversion D −378 786 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series C Preferred Stock C - Conversion D −378 786 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series C Preferred Stock C - Conversion D 378 786 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series B-2 Preferred Stock C - Conversion D −325 035 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series B-2 Exchangeable Shares C - Conversion D −325 035 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series B-2 Preferred Stock C - Conversion D 325 035 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series B-1 Exchangeable Shares C - Conversion D −326 538 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series B-1 Preferred Stock C - Conversion D −326 538 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series B-1 Preferred Stock C - Conversion D 326 538 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series A-2 Exchangeable Shares C - Conversion D −189 393 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series A-2 Preferred Stock C - Conversion D −189 393 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series A-2 Preferred Stock C - Conversion D 189 393 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series A-1 Preferred Stock C - Conversion D −284 090 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series A-1 Exchangeable Shares C - Conversion D −284 090 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series A-1 Preferred Stock C - Conversion D 284 090 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Common Exchangeable Shares C - Conversion D −40 147 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Common Exchangeable Shares A - Award D 11,0000 36 502 402 40 147
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Common Stock C - Conversion D 1 543 989 1 543 989
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series C Special Voting Stock D - Sale to Issuer D −378 786 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series B-2 Special Voting Stock D - Sale to Issuer D −325 035 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series B-1 Special Voting Stock D - Sale to Issuer D −326 538 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series A-2 Special Voting Stock D - Sale to Issuer D −189 393 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Series A-1 Special Voting Stock D - Sale to Issuer D −284 090 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Common Special Voting Stock D - Sale to Issuer D −40 147 0
2014-03-14 2014-03-12 4 Ventures West 8 Limited Partnership AQXP Common Special Voting Stock A - Award D 36 502 40 147
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series C Preferred Stock C - Conversion I −378 786 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series C Exchangeable Shares C - Conversion I −378 786 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series C Preferred Stock C - Conversion I 378 786 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series B-2 Preferred Stock C - Conversion I −325 035 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series B-2 Exchangeable Shares C - Conversion I −325 035 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series B-2 Preferred Stock C - Conversion I 325 035 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series B-1 Exchangeable Shares C - Conversion I −326 538 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series B-1 Preferred Stock C - Conversion I −326 538 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series B-1 Preferred Stock C - Conversion I 326 538 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series A-2 Exchangeable Shares C - Conversion I −189 393 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series A-2 Preferred Stock C - Conversion I −189 393 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series A-2 Preferred Stock C - Conversion I 189 393 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series A-1 Exchangeable Shares C - Conversion I −284 090 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series A-1 Preferred Stock C - Conversion I −284 090 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series A-1 Preferred Stock C - Conversion I 284 090 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Common Exchangeable Shares C - Conversion I −40 147 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Common Exchangeable Shares A - Award I 11,0000 36 502 402 40 147
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Common Stock C - Conversion I 1 543 989 1 543 989
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series C Special Voting Stock D - Sale to Issuer I −378 786 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series B-2 Special Voting Stock D - Sale to Issuer I −325 035 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series B-1 Special Voting Stock D - Sale to Issuer I −326 538 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series A-2 Special Voting Stock D - Sale to Issuer I −189 393 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Series A-1 Special Voting Stock D - Sale to Issuer I −284 090 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Common Special Voting Stock D - Sale to Issuer I −40 147 0
2014-03-14 2014-03-12 4 Bridger Gary See Note AQXP Common Special Voting Stock A - Award I 36 502 40 147
2014-03-14 2014-03-12 4 PFIZER INC AQXP Series C Preferred Stock C - Conversion D −301 005 0
2014-03-14 2014-03-12 4 PFIZER INC AQXP Series B-2 Preferred Stock C - Conversion D −327 178 0
2014-03-14 2014-03-12 4 PFIZER INC AQXP Series B-1 Preferred Stock C - Conversion D −334 420 0
2014-03-14 2014-03-12 4 PFIZER INC AQXP Common Stock P - Purchase D 11,0000 272 727 3 000 1 235 330
2014-03-14 2014-03-12 4 PFIZER INC AQXP Common Stock C - Conversion D 962 603 962 603
2014-03-12 2014-03-12 4 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation AQXP Series C Preferred Stock C - Conversion I −379 543 0
2014-03-12 2014-03-12 4 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation AQXP Series B-2 Preferred Stock C - Conversion I −292 532 0
2014-03-12 2014-03-12 4 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation AQXP Series B-1 Preferred Stock C - Conversion I −293 884 0
2014-03-12 2014-03-12 4 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation AQXP Series A-2 Preferred Stock C - Conversion I −170 454 0
2014-03-12 2014-03-12 4 JOHNSON & JOHNSON By Johnson & Johnson Development Corporation AQXP Series A-1 Preferred Stock C - Conversion I −255 681 0
2014-03-12 2014-03-12 4 JOHNSON & JOHNSON Johnson & Johnson Development Corporation AQXP Common Stock C - Conversion I 1 392 094 1 392 094
2014-03-10 2014-03-06 4 SIMPSON TODD E AQXP Stock Option (Right to Buy) A - Award D 11,00 8 333 8 333
2014-03-10 2014-03-06 4 Pelzer Robert AQXP Stock Option (Right to Buy) A - Award D 11,00 8 333 14 843
2014-03-10 2014-03-06 4 LEVITT DANIEL J AQXP Stock Option (Right to Buy) A - Award D 11,00 8 333 20 051
2014-03-10 2014-03-06 4 Bridger Gary AQXP Stock Option (Right to Buy) A - Award D 11,00 8 333 8 333
2014-03-06 3 Jones Elaine V AQXP No securities are beneficially owned D 0
2014-03-06 3 SIMPSON TODD E AQXP No securities are beneficially owned D 0
2014-03-06 3 Main David AQXP Common Special Voting Stock D 161 978
2014-03-06 3 Main David AQXP Common Special Voting Stock D 161 978
2014-03-06 3 Ventures West 8 Limited Partnership AQXP Common Special Voting Stock D 1 511 132
2014-03-06 3 Ventures West 8 Limited Partnership AQXP Series B-2 Special Voting Stock D 1 832 522
2014-03-06 3 Ventures West 8 Limited Partnership AQXP Common Special Voting Stock D 1 511 132
2014-03-06 3 Ventures West 8 Limited Partnership AQXP Series A- Special Voting Stock D 1 791 577
2014-03-06 3 Ventures West 8 Limited Partnership AQXP Series A-2 Special Voting Stock D 1 696 880
2014-03-06 3 Ventures West 8 Limited Partnership AQXP Series A- Special Voting Stock D 1 791 577
2014-03-06 3 Ventures West 8 Limited Partnership AQXP Series B-1 Special Voting Stock D 1 834 025
2014-03-06 3 Ventures West 8 Limited Partnership AQXP Series B-2 Special Voting Stock D 1 832 522
2014-03-06 3 Ventures West 8 Limited Partnership AQXP Series C Special Voting Stock D 1 886 273
2014-03-06 3 Ventures West 8 Limited Partnership AQXP Series C Special Voting Stock D 1 886 273
2014-03-06 3 Ventures West 8 Limited Partnership AQXP Series A-2 Special Voting Stock D 1 696 880
2014-03-06 3 Ventures West 8 Limited Partnership AQXP Series B-1 Special Voting Stock D 1 834 025
2014-03-06 3 Bridger Gary See Note (9) AQXP Series A-2 Special Voting Stock I 1 696 880
2014-03-06 3 Bridger Gary See Note (9) AQXP Series C Special Voting Stock I 1 886 273
2014-03-06 3 Bridger Gary See Note (9) AQXP Series B-2 Special Voting Stock I 1 832 522
2014-03-06 3 Bridger Gary See Note (9) AQXP Series B-1 Special Voting Stock I 1 834 025
2014-03-06 3 Bridger Gary See Note (9) AQXP Common Special Voting Stock I 1 511 132
2014-03-06 3 Bridger Gary See Note (9) AQXP Series A-2 Special Voting Stock I 1 696 880
2014-03-06 3 Bridger Gary See Note (9) AQXP Series A-1 Special Voting Stock I 1 791 577
2014-03-06 3 Bridger Gary See Note (9) AQXP Series B-1 Special Voting Stock I 1 834 025
2014-03-06 3 Bridger Gary See Note (9) AQXP Common Special Voting Stock I 1 511 132
2014-03-06 3 Bridger Gary See Note (9) AQXP Series B-2 Special Voting Stock I 1 832 522
2014-03-06 3 Bridger Gary See Note (9) AQXP Series C Special Voting Stock I 1 886 273
2014-03-06 3 Bridger Gary See Note (9) AQXP Series A-1 Special Voting Stock I 1 791 577
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista